Statistics
Publications
3
Citations
68
H-Index
3
Active since
2020
Affiliations
Sandeep Dhanda is an author at Drug Safety Research Unit specializing in preventive medicine, post-market surveillance, and benefit-risk management plans.
Publications per year
2020–2020
3
3
Lopinavir-Ritonavir in treatment of COVID-19: A dynamic systematic benefit-risk assessment
Vicki Osborne, Miranda Davies, Samantha Lane et al. · medRxiv · 2020 · 16 citations · Full text
Remdesivir in treatment of COVID-19: A systematic benefit-risk assessment
Miranda Davies, Vicki Osborne, Samantha Lane et al. · medRxiv · 2020 · 11 citations · Full text
1–3 of 3